======= ST3GAL2 =======
== Gene Information ==
* **Official Symbol**: ST3GAL2
* **Official Name**: ST3 beta-galactoside alpha-2,3-sialyltransferase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6483|6483]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q16842|Q16842]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ST3GAL2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ST3GAL2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607188|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The encoded protein is normally found in the Golgi but can be proteolytically processed to a soluble form. This protein, which is a member of glycosyltransferase family 29, can use the same acceptor substrates as does sialyltransferase 4A. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Responsible for the synthesis of the sequence NeuAc- alpha-2,3-Gal-beta-1,3-GalNAc- found in terminal carbohydrate groups of certain glycoproteins, oligosaccharides and glycolipids. SIAT4A and SIAT4B sialylate the same acceptor substrates but exhibit different Km values. {ECO:0000250|UniProtKB:Q11204}.
|Glyco transf 29|
|monosialoganglioside sialyltransferase activity|
|beta-galactoside (CMP) alpha-2,3-sialyltransferase activity|
|protein sialylation|
|lipid glycosylation|
|oligosaccharide biosynthetic process|
|sialylation|
|keratan sulfate biosynthetic process|
|keratan sulfate metabolic process|
|oligosaccharide metabolic process|
|O-glycan processing|
|glycolipid biosynthetic process|
|Golgi cisterna membrane|
|glycosaminoglycan biosynthetic process|
|mucopolysaccharide metabolic process|
|aminoglycan biosynthetic process|
|glycolipid metabolic process|
|liposaccharide metabolic process|
|protein O-linked glycosylation|
|carbohydrate biosynthetic process|
|membrane lipid biosynthetic process|
|glycosaminoglycan metabolic process|
|aminoglycan metabolic process|
|sulfur compound biosynthetic process|
|lipid modification|
|membrane lipid metabolic process|
|protein glycosylation|
|macromolecule glycosylation|
|glycosylation|
|glycoprotein biosynthetic process|
|sulfur compound metabolic process|
|glycoprotein metabolic process|
|carbohydrate metabolic process|
|lipid biosynthetic process|
|carbohydrate derivative biosynthetic process|
|Golgi membrane|
|cellular lipid metabolic process|
|oxoacid metabolic process|
|organic acid metabolic process|
|carbohydrate derivative metabolic process|
|lipid metabolic process|
|organonitrogen compound biosynthetic process|
|cellular macromolecule biosynthetic process|
|small molecule metabolic process|
|macromolecule biosynthetic process|
|extracellular region|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|-2|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5022
* **Expression level (log2 read counts)**: 6.14
{{:chemogenomics:nalm6 dist.png?nolink |}}